D. Teitelbaum

409 total citations
15 papers, 323 citations indexed

About

D. Teitelbaum is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, D. Teitelbaum has authored 15 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in D. Teitelbaum's work include Immunotherapy and Immune Responses (6 papers), Multiple Sclerosis Research Studies (3 papers) and Diabetes and associated disorders (2 papers). D. Teitelbaum is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Multiple Sclerosis Research Studies (3 papers) and Diabetes and associated disorders (2 papers). D. Teitelbaum collaborates with scholars based in Israel, United States and Japan. D. Teitelbaum's co-authors include Michael Sela, Ruth Arnon, Rina Aharoni, Murray B. Bornstein, Ruth Arnon, Ilan Krause, A. Afek, Iris Goldberg, Dan Buskila and Miri Blank and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

D. Teitelbaum

14 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Teitelbaum Israel 9 170 138 69 67 50 15 323
Manuel San United States 5 257 1.5× 147 1.1× 36 0.5× 53 0.8× 51 1.0× 6 385
S. Galgani Italy 12 213 1.3× 226 1.6× 120 1.7× 97 1.4× 88 1.8× 15 533
Christopher LaGanke United States 9 66 0.4× 193 1.4× 80 1.2× 65 1.0× 72 1.4× 28 287
М. А. Судомоина Russia 13 152 0.9× 127 0.9× 25 0.4× 50 0.7× 74 1.5× 24 431
Tadashi Namikawa Japan 8 217 1.3× 81 0.6× 32 0.5× 38 0.6× 27 0.5× 14 333
Sonja Ortler Germany 10 219 1.3× 96 0.7× 55 0.8× 24 0.4× 80 1.6× 17 399
David D. Hebrink United States 13 264 1.6× 207 1.5× 38 0.6× 103 1.5× 76 1.5× 16 495
Ilse A Hoppenbrouwers Netherlands 9 167 1.0× 228 1.7× 23 0.3× 71 1.1× 55 1.1× 10 419
Claudia Luther Germany 9 231 1.4× 54 0.4× 88 1.3× 17 0.3× 53 1.1× 10 405
René M. Gieß Germany 11 74 0.4× 224 1.6× 73 1.1× 69 1.0× 71 1.4× 16 333

Countries citing papers authored by D. Teitelbaum

Since Specialization
Citations

This map shows the geographic impact of D. Teitelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Teitelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Teitelbaum more than expected).

Fields of papers citing papers by D. Teitelbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Teitelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Teitelbaum. The network helps show where D. Teitelbaum may publish in the future.

Co-authorship network of co-authors of D. Teitelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of D. Teitelbaum. A scholar is included among the top collaborators of D. Teitelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Teitelbaum. D. Teitelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Teitelbaum, D., Ruth Arnon, & Michael Sela. (1998). Immunomodulation of experimental allergic encephalomyelitis by oral administration of Copolymer 1 (Copaxone®). Journal of Neuroimmunology. 90(1). 85–85. 1 indexed citations
2.
Teitelbaum, D., Ruth Arnon, & Michael Sela. (1997). Cop 1 as a candidate drug for multiple sclerosis. PubMed. 49. 85–91. 11 indexed citations
3.
Aharoni, Rina, D. Teitelbaum, Ruth Arnon, & Michael Sela. (1997). 2-31-01 Copolymer 1 inhibits the response to myelin basic protein p84-102 by T cell receptor antagonism in addition to MHC blocking. Journal of the Neurological Sciences. 150. S115–S116. 2 indexed citations
4.
Teitelbaum, D., Rina Aharoni, Michael Sela, & Ruth Arnon. (1997). 3-31-25 Suppression of experimental allergic encephalomyelitis by oral administration of copolymer 1 (copaxone®). Journal of the Neurological Sciences. 150. S188–S188. 1 indexed citations
5.
6.
Blank, Miri, Ilan Krause, Dan Buskila, et al.. (1995). Bromocriptine Immunomodulation of Experimental SLE and Primary Anti-phospholipid Syndrome via Induction of Nonspecific T Suppressor Cells. Cellular Immunology. 162(1). 114–122. 52 indexed citations
7.
Teitelbaum, D., Masha Fridkis‐Hareli, Ruth Arnon, & Michael Sela. (1995). Copolymer 1 suppresses chronic-relapsing eae induced in mice by PLP encephalitogenic peptides and interferes with the immune response to these peptides. Journal of Neuroimmunology. 56-63. 19–19. 1 indexed citations
8.
Arnon, Ruth & D. Teitelbaum. (1994). Immunospecific drug design--prospects for treatment of autoimmune diseases.. PubMed. 1(1). 65–70. 1 indexed citations
9.
Teitelbaum, D., Rina Aharoni, Michael Sela, & Ruth Arnon. (1991). Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1.. Proceedings of the National Academy of Sciences. 88(21). 9528–9532. 69 indexed citations
10.
Arnon, Ruth, D. Teitelbaum, & Michael Sela. (1989). Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis.. PubMed. 25(12). 686–9. 13 indexed citations
11.
Segał, P, D. Teitelbaum, & A Ohry. (1983). Cell-mediated immunity to nervous system antigens in diabetic patients with neuropathy.. PubMed. 19(1). 7–10. 3 indexed citations
12.
Bornstein, Murray B., et al.. (1982). Multiple sclerosis: Trial of a synthetic polypeptide. Annals of Neurology. 11(3). 317–319. 69 indexed citations
13.
Lando, Zeev, D. Teitelbaum, & Ruth Arnon. (1981). The immunologic response in mice unresponsive to experimental allergic encephalomyelitis.. The Journal of Immunology. 126(4). 1526–1528. 17 indexed citations
14.
Abramsky, Oded, et al.. (1980). Association with autoimmune diseases and cellular immune response to the neuritogenic protein in Guillain-Barré syndrome.. PubMed. 105. 350–4. 13 indexed citations
15.
Teitelbaum, D., Cynthia Webb, A. Meshorer, Ruth Arnon, & Michael Sela. (1972). Protection against Experimental Allergic Encephalomyelitis. Nature. 240(5383). 564–566. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel San Breakdown of academic impact, for papers by S. Galgani Breakdown of academic impact, for papers by Christopher LaGanke Breakdown of academic impact, for papers by М. А. Судомоина Breakdown of academic impact, for papers by Tadashi Namikawa Breakdown of academic impact, for papers by Sonja Ortler Breakdown of academic impact, for papers by David D. Hebrink Breakdown of academic impact, for papers by Ilse A Hoppenbrouwers Breakdown of academic impact, for papers by Claudia Luther Breakdown of academic impact, for papers by René M. Gieß
Rankless by CCL
2026